Severe skin reactions investigated with valsartan in Japan

The Japanese health ministry, along with the Pharmaceuticals and Medical Devices Agency, is currently determining whether the adverse effect should be added to the drug's label. An expected change in the label will come next month, according to Novartis.
Source: theHeart.org - Category: Cardiology Source Type: news